Old Web
English
Sign In
Acemap
>
authorDetail
>
Carolyn Darmiento
Carolyn Darmiento
Merck & Co.
Endocrinology
Sitagliptin
Diabetes mellitus
Internal medicine
Clinical trial
2
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and Safety of Continuing Sitagliptin when Initiating Insulin Therapy in Subjects with Type 2 Diabetes Mellitus
2018
Diabetes
Ronan Roussel
Santiago Durán-García
Yilong Zhang
Suneri Shah
Carolyn Darmiento
R. Ravi Shankar
Edward A. O’Neill
Gregory T. Golm
Raymond Lam
Ira Gantz
Keith D. Kaufman
Samuel S. Engel
Show All
Source
Cite
Save
Citations (2)
Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study
2018
Diabetes, Obesity and Metabolism
Ronan Roussel
Santiago Durán-García
Yilong Zhang
Suneri Shah
Carolyn Darmiento
R. Ravi Shankar
Gregory T. Golm
Raymond Lam
Edward A. O’Neill
Ira Gantz
Keith D. Kaufman
Samuel S. Engel
Show All
Source
Cite
Save
Citations (11)
1